Medically important Candida spp. identification: an era beyond traditional methods.

BACKGROUND Candida infections are gaining more attention for the last few decades so diagnostic tools are very important for early diagnosis. Conventional identification of yeasts is time-consuming, molecular methods are more complicated and relatively expensive gold-standard methods. Matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) was put into the market due to its speed and high accuracy. The aim of this study was to evaluate the performance of corn meal tween-80 agar (CMTA), CHROMagar Candida medium, and MALDI-TOF MS and to compare the obtained results with DNA sequencing. METHODS The CHROMagar Candida medium, CMTA, and MALDI-TOF MS Biotyper System were used to test 416 isolates. The isolates with discrepant results by at least one of the three methods were subjected to sequence analysis. RESULTS The identification results of the 351 (%84.4) were compatible with all three methods. When compared to the sequencing results, the most accurate results were obtained by the MALDI-TOF MS, especially for rare Candida species. DISCUSSION MALDI-TOF MS is found to be the most accurate identification tool for clinically important Candida strains. CMTA alone should not be used for the final identification of Candida species and the chromogenic medium should always be considered presumptive.

[1]  R. Ben-Ami Treatment of Invasive Candidiasis: A Narrative Review , 2018, Journal of fungi.

[2]  S. Deorukhkar,et al.  Identification of Candida Species: Conventional Methods in the Era of Molecular Diagnosis , 2018 .

[3]  S. Shakoor,et al.  Identification of Candida species by direct inoculation of cornmeal tween™ 80 agar from blood culture bottles: Rapid and cost-effective approach , 2018 .

[4]  M. Netea,et al.  Patient Susceptibility to Candidiasis—A Potential for Adjunctive Immunotherapy , 2018, Journal of fungi.

[5]  S. Barnini,et al.  Comparative evaluation of six chromogenic media for presumptive yeast identification , 2017, Journal of Clinical Pathology.

[6]  J. Perfect The antifungal pipeline: a reality check , 2017, Nature Reviews Drug Discovery.

[7]  S. Ranque,et al.  Performance of MALDI‐TOF MS platforms for fungal identification , 2016, Mycoses.

[8]  S. Brunke,et al.  Candida species Rewired Hyphae Developmental Programs for Chlamydospore Formation , 2016, Front. Microbiol..

[9]  K. Ackermann,et al.  Medically Important Fungi A Guide To Identification , 2016 .

[10]  M. N. Souza,et al.  COMPARISON BETWEEN FOUR USUAL METHODS OF IDENTIFICATION OF Candida SPECIES , 2015, Revista do Instituto de Medicina Tropical de Sao Paulo.

[11]  Yuichi Sakamoto,et al.  Retrospective analysis of mortality and Candida isolates of 75 patients with candidemia : a single hospital experience , 2015 .

[12]  E. Leoncini,et al.  Are the Conventional Commercial Yeast Identification Methods Still Helpful in the Era of New Clinical Microbiology Diagnostics? A Meta-Analysis of Their Accuracy , 2015, Journal of Clinical Microbiology.

[13]  P. C. Ribeiro,et al.  Clinical significance of the isolation of Candida species from hospitalized patients , 2015, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].

[14]  D. Sullivan,et al.  Identification and characterization of nine atypical Candida dubliniensis clinical isolates. , 2015, Journal of medical microbiology.

[15]  B. Kullberg,et al.  Invasive Candidiasis. , 2015, The New England journal of medicine.

[16]  S. Khan,et al.  Identifying Candida and other yeast-like fungi: utility of an identification algorithm in resource limited setting. , 2014, Journal of clinical and diagnostic research : JCDR.

[17]  K. Kristóf,et al.  Candida bloodstream infection: a clinical microbiology laboratory perspective. , 2014, Acta microbiologica et immunologica Hungarica.

[18]  T. Perl,et al.  Epidemiology of Candida kefyr in Patients with Hematologic Malignancies , 2014, Journal of Clinical Microbiology.

[19]  X. Nassif,et al.  Evaluation of two matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) systems for the identification of Candida species. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[20]  L. Hensgens,et al.  Identification and typing of the Candida parapsilosis complex: MALDI-TOF MS vs. AFLP. , 2014, Medical mycology.

[21]  M. Arendrup,et al.  Performance of matrix‐assisted laser desorption‐time of flight mass spectrometry for identification of clinical yeast isolates , 2013, Mycoses.

[22]  B. Posteraro,et al.  MALDI-TOF mass spectrometry in the clinical mycology laboratory: identification of fungi and beyond , 2013, Expert review of proteomics.

[23]  A. Borman,et al.  Assessment of Accuracy of Identification of Pathogenic Yeasts in Microbiology Laboratories in the United Kingdom , 2012, Journal of Clinical Microbiology.

[24]  Smitha Byadarahally Raju,et al.  Isolation and Identification of Candida from the Oral Cavity , 2011, ISRN dentistry.

[25]  P. Sudbery Growth of Candida albicans hyphae , 2011, Nature Reviews Microbiology.

[26]  L. Hall,et al.  Performance and Cost Analysis of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry for Routine Identification of Yeast , 2011, Journal of Clinical Microbiology.

[27]  E. Swiatlo,et al.  Misidentification of Candida parapsilosis as C famata in a clinical case of vertebral osteomyelitis. , 2011, The American journal of the medical sciences.

[28]  A. Bizzini,et al.  Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, a revolution in clinical microbial identification. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[29]  S. Orenga,et al.  Yeast identification--past, present, and future methods. , 2007, Medical mycology.

[30]  L. C. Spolidorio,et al.  Phenotypic methods and commercial systems for the discrimination between C. albicans and C. dubliniensis. , 2005, Oral diseases.

[31]  G. Quindós,et al.  Supplementation of CHROMagar Candida Medium with Pal's Medium for Rapid Identification of Candida dubliniensis , 2005, Journal of Clinical Microbiology.

[32]  M. Murray,et al.  CHROMagar Candida as the Sole Primary Medium for Isolation of Yeasts and as a Source Medium for the Rapid-Assimilation-of-Trehalose Test , 2005, Journal of Clinical Microbiology.

[33]  A. Mitchell,et al.  Genetic control of chlamydospore formation in Candida albicans. , 2003, Microbiology.

[34]  D. Hospenthal,et al.  Direct Isolation of Candida spp. from Blood Cultures on the Chromogenic Medium CHROMagar Candida , 2003, Journal of Clinical Microbiology.

[35]  D. Soll The Ins and Outs of DNA Fingerprinting the Infectious Fungi , 2000, Clinical Microbiology Reviews.

[36]  G. Skiniotis,et al.  Identification of medically significant fungal genera by polymerase chain reaction followed by restriction enzyme analysis. , 1999, FEMS immunology and medical microbiology.

[37]  G. Moran,et al.  Candidiasis: the emergence of a novel species, Candida dubliniensis , 1997, AIDS.